SERIO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 18.116
EU - Europa 12.650
AS - Asia 5.407
SA - Sud America 765
OC - Oceania 170
AF - Africa 147
Continente sconosciuto - Info sul continente non disponibili 6
Totale 37.261
Nazione #
US - Stati Uniti d'America 17.990
PL - Polonia 3.889
RU - Federazione Russa 3.633
SG - Singapore 1.745
SE - Svezia 1.226
HK - Hong Kong 1.093
CN - Cina 999
IE - Irlanda 917
IT - Italia 673
UA - Ucraina 669
DE - Germania 635
BR - Brasile 630
KR - Corea 605
FI - Finlandia 332
IN - India 255
GB - Regno Unito 234
VN - Vietnam 229
AU - Australia 162
CH - Svizzera 143
FR - Francia 132
JO - Giordania 132
TR - Turchia 73
CA - Canada 65
JP - Giappone 57
AR - Argentina 45
BE - Belgio 42
CI - Costa d'Avorio 42
IQ - Iraq 40
ID - Indonesia 37
AT - Austria 36
BD - Bangladesh 34
MX - Messico 34
NL - Olanda 33
EC - Ecuador 26
ZA - Sudafrica 26
SC - Seychelles 20
VE - Venezuela 20
ES - Italia 19
MA - Marocco 14
PY - Paraguay 13
PK - Pakistan 12
LT - Lituania 10
UZ - Uzbekistan 10
EG - Egitto 9
NP - Nepal 9
CO - Colombia 8
NZ - Nuova Zelanda 8
PH - Filippine 8
SA - Arabia Saudita 8
TN - Tunisia 8
AZ - Azerbaigian 7
CL - Cile 7
DZ - Algeria 7
JM - Giamaica 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
KE - Kenya 6
KG - Kirghizistan 6
PE - Perù 6
BO - Bolivia 5
EU - Europa 5
IL - Israele 5
MU - Mauritius 5
UY - Uruguay 5
LA - Repubblica Popolare Democratica del Laos 4
OM - Oman 4
AL - Albania 3
AM - Armenia 3
CZ - Repubblica Ceca 3
GE - Georgia 3
HU - Ungheria 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
RO - Romania 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BJ - Benin 2
DK - Danimarca 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
LK - Sri Lanka 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GM - Gambi 1
GT - Guatemala 1
Totale 37.245
Città #
Warsaw 3.887
Santa Clara 3.082
Fairfield 1.811
Ashburn 1.504
Chandler 1.186
Jacksonville 1.176
Singapore 1.151
Dublin 916
Woodbridge 911
Hong Kong 897
Cambridge 790
Seattle 778
Houston 683
Wilmington 630
Seoul 575
Ann Arbor 387
Beijing 333
Buffalo 291
Los Angeles 280
San Jose 265
Princeton 250
Lawrence 242
Altamura 230
Boardman 217
Hefei 178
Boston 176
The Dalles 166
Dallas 159
Melbourne 158
Mumbai 147
Bern 143
Munich 141
Medford 132
New York 114
San Diego 113
Moscow 104
Shanghai 76
Paris 69
Florence 59
Ho Chi Minh City 59
Milan 54
Norwalk 54
Dong Ket 53
Tokyo 53
Kent 52
Turku 51
Izmir 46
Pune 44
São Paulo 44
Abidjan 42
Auburn Hills 40
Council Bluffs 40
Hanoi 38
Brussels 37
Hillsboro 37
Falls Church 36
Helsinki 33
Jakarta 32
Vienna 29
Andover 28
Phoenix 28
West Jordan 28
Frankfurt Am Main 27
Yubileyny 27
London 25
Seongnam 25
Chicago 24
Rio de Janeiro 22
Toronto 22
Verona 21
Baghdad 19
Brasília 18
Campinas 17
Frankfurt am Main 17
Redondo Beach 16
Tianjin 16
Belo Horizonte 15
Brooklyn 15
Montreal 15
Amman 14
Atlanta 14
Denver 13
Guayaquil 13
Salerno 12
Orem 11
Rome 11
Stockholm 11
Ankara 10
Chennai 10
Johannesburg 10
Curitiba 9
Haiphong 9
Laurel 9
Tashkent 9
Amsterdam 8
Bremen 8
Charlotte 8
Dearborn 8
Guangzhou 8
Naples 8
Totale 25.919
Nome #
Gonadotropin-releasing hormone modulates cholesterol synthesis and steroidogenesis in SH-SY5Y cells. 377
Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1 360
Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell 352
Characterization of human adult stem cell populations isolated from visceral and subcutaneous adipose tissue. 348
Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer. 336
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 326
Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor 317
19-nor-10-azasteroids, a new class of steroid 5a-reductase inhibitors. 2. X-ray structure, molecular modeling, conformational analysis of 19-nor-10-azasteroids and comparison with 4-azasteroids and 6-azasteroids 316
Seladin-1 as a target of estrogen receptor activation in the brain: a new gene for a rather old story? 313
5alpha-Reductase Activity in Lycopersicon Esculentum: Cloning and Functional Characterization of Ledet2 and Evidences of the Presence of Two Isoenzymes 313
Expression of functional estrogen receptors in human fetal male external genitalia 311
Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog. 305
Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures 303
Seladin-1/dhcr24 protects neuroblastoma cells against aβ toxicity by increasing membrane cholesterol content 296
Synthesis of benzo[c]quinolizin-3-ones: selective non steroidal inhibitors of steroid 5a-Reductase 1 292
5alpha-reductase ihnibitors, chemical and clinical models 277
19-nor-10-azasteroids: a novel class of inhibitors for human steroid 5alpha-reductases 1 and 2 276
New Evidence of Similarity between Human and Plant Steroid Metabolism: 5alpha-Reductase Activity in Solanum malacoxylon 276
Benzo[c]quinolizin-3-ones: a novel class of potent and selective nonsteroidal inhibitors of human steroid 5alpha-reductase 1 274
Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. 270
Synthesis of 5,6,6-[2H3]finasteride and quantitative determination of finasteride in human plasma at picogram level by an isotope-dilution mass spectrometric method. 270
Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. 270
PPARgamma in Neuroblastoma. 249
Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa. 246
Isotopic dilution GC-MS measurement of 4-Hydroxyandrostendione in postmenopausal breast cancer 244
Prognostic value of somatostatin receptor subtype 2 expression in colorectal cancer 242
Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A. 240
Synthesis of a chemiluminescent probe useful for the purification of steroid 5a-reductase 239
Pharmacokinetics of 4-hydroxyandrostenedione in man after intramuscular injection of different formulations and the effect of this drug on plasma aromatizable androgens and 17beta-estradiol concentrations. 233
Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A) 215
Regeneration of Glomerular Podocytes by Human Renal Progenitors. 214
Immunosuppression in cardiac graft rejection: a human in vitro model to study the potential use of new immunomodulatory drugs. 208
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells 206
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 204
Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy. 199
Effect of a Vitamin D3 Analogue on Keratinocyte Growth Factor-Induced Cell Proliferation in Benign Prostate Hyperplasia 199
Immunologically reactive albumin-like protein in human testis and seminal plasma. 197
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. 195
CXC chemokines: the regulatory link between inflammation and angiogenesis 191
Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism. 189
A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters. 188
5A-REDUCTASE INHIBITORS, CHEMICAL AND CLINICAL MODELS 188
Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys 187
Somatostatin receptors and breast cancer 186
Vitamin D3 analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells. 186
IDENTIFICATION AND LOCALIZATION OF ENDOTHELIN-1 AND ITS RECEPTORS IN HUMAN FETAL JAWS. 185
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 184
Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1) 184
A case of hyponatremia caused by central hypocortisolism 179
Expression and biological effects of endothelin-1 in human gonadotropin-releasing hormone-secreting neurons 179
Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. 178
Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells. 177
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. 176
Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes. 175
Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue 175
Natriuretic peptides exhibit specific receptors on cultured parathyroid cells linked to endothelin synthesis and release. 175
Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. 174
IMMUNOLOCALIZATION, BINDING, AND BIOLOGICAL ACTIVITY OF ENDOTHELIN IN RABBIT UTERUS: EFFECT OF OVARIAN STEROIDS. 174
PF-4/CXCL4 and CXCLAL1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion 174
Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas. 173
ANTAGONISTS FOR THE HUMAN OXYTOCIN RECEPTOR: AN IN VITRO STUDY. 173
Regenerative potential of embryonic renal multipotent progenitors in acute renal failure 173
Sertoli-germ cells interactions in the human testis 172
Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium. 172
ENDOTHELIN IN RABBIT UTERUS DURING PREGNANCY. 171
Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors. 170
Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. 170
INSULIN-LIKE GROWTH FACTOR-I RECEPTORS IN NONFUNCTIONING THYROID NODULES. 169
A study on human adrenal secretion. Measurement of epinephrine, norepinephrine, dopamine and cortisol in peripheral and adrenal venous blood under surgical stress. 169
Sertoli cell proteins in the human seminiferous tubule. 168
Cushing's syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection 167
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. 167
Effects of thyroid replacement therapy on catecholamine plasma levels. 167
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. 166
Localization of endothelin-converting enzyme-1 in human kidney 165
Adrenal medulla secretion in Cushing's syndrome. 165
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. 164
Effect of C-Ring Modifications in Benzo[c]quinolizin-3-ones, New Selective Inhibitors of Human 5a-Reductase 1 164
Immunoassayable somatomedin C in seminal plasma of azoospermic men. 163
Androgen-binding protein and other Sertoli cell proteins in human testis. 163
Age-related secretion of androstenedione, testosterone and dihydrotestosterone by the human testis. 163
SEX STEROIDS AND ODORANTS MODULATE GONADOTROPIN-RELEASING HORMONE SECRETION IN PRIMARY CULTURES OF HUMAN OLFACTORY CELLS. 163
Measurement of steroids in human plasma and tissues by isotope dilution mass spectrometry. 162
Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. 161
Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells. 161
Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity 160
Identification and characterization of functional angiotensin II receptors in human neuroblastoma cells. 159
Neurohypophyseal hormone regulation of endothelin secretion from rabbit endometrial cells in primary culture. 159
INSULIN-LIKE GROWTH FACTOR-I RECEPTORS IN HUMAN HYPERPLASTIC PROSTATE TISSUE: CHARACTERIZATION, TISSUE LOCALIZATION, AND THEIR MODULATION BY CHRONIC TREATMENT WITH A GONADOTROPIN-RELEASING HORMONE ANALOG. 158
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome. 158
GENE EXPRESSION OF ENDOTHELIN-1, ENDOTHELIN-CONVERTING ENZYME-1, AND ENDOTHELIN RECEPTORS IN HUMAN EPIDIDYMIS 158
Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours. 158
EXPRESSION AND CELLULAR LOCALIZATION OF KERATINOCYTE GROWTH FACTOR AND ITS RECEPTOR IN HUMAN HYPERPLASTIC PROSTATE TISSUE 157
A solid phase chemiluminescent immunoassay (LIA) for testosterone glicuronide in diluted urines. 157
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 157
Insulin-like growth factor-I (IGF-I) and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization 156
Presence and distribution of endothelin-1 gene expression in human kidney. 156
Epidermal growth factor, epidermal growth factor receptor, and transforming growth factor-alpha in human hyperplastic prostate tissue: expression and cellular localization. 155
Functional estrogen receptors in a human preosteoclastic cell line. 155
Aromatase expression and activity in the human leukaemic cell line FLG 29.1. 155
Totale 20.811
Categoria #
all - tutte 99.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.734 0 0 0 0 0 0 124 357 266 492 173 322
2021/20221.808 72 187 106 61 77 77 88 79 98 90 431 442
2022/20234.598 423 767 189 390 387 834 551 233 484 32 124 184
2023/20241.470 57 181 259 69 119 229 45 336 17 54 60 44
2024/20259.505 336 1.040 634 1.528 2.853 1.037 142 550 537 260 331 257
2025/20266.094 1.268 1.403 650 718 1.215 427 413 0 0 0 0 0
Totale 37.352